This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of Michigan. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Matthew Iyer: Innovator in Cancer Research
Introduction
Matthew Iyer is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work focuses on the development of diagnostic markers and therapeutic targets for various types of cancer.
Latest Patents
Iyer's latest patents include innovative compositions and methods for cancer diagnosis, research, and therapy. One of his notable inventions relates to non-coding RNAs (ncRNAs) as diagnostic markers and clinical targets for prostate, lung, breast, and pancreatic cancer. This groundbreaking work aims to enhance cancer diagnosis and treatment options.
Career Highlights
Matthew Iyer is affiliated with the University of Michigan, where he conducts his research and development. His work has garnered attention for its potential impact on cancer diagnostics and therapeutics.
Collaborations
Iyer collaborates with esteemed colleagues, including Arul M Chinnaiyan and John Prensner, to advance the understanding and treatment of cancer.
Conclusion
Matthew Iyer's contributions to cancer research through his patents and collaborations highlight his commitment to improving cancer diagnosis and therapy. His innovative work continues to pave the way for advancements in the medical field.